Award

Delivery Order #SPE2DP26F3213

Short-Term Delivery Order for Mafenide Acetate by DMS Pharmaceutical Group

Buyer

Defense Logistics Agency

Award Amount

$1,961.10

Ceiling

$1,961.10

Awarded

March 02, 2026

Period of Performance

Mar 02, 2026 – Mar 17, 2026

Identifier

SPE2DP26F3213

NAICS

424210

This contract is a delivery order under a pre-existing indefinite delivery vehicle (IDV) definitive pharmaceutical supply contract. The recipient, DMS Pharmaceutical Group Inc., a pharmaceutical distributor known for supplying critical drug inventories to federal health agencies, is tasked with providing Mafenide Acetate cream. This product is significant for its role in treating burn wounds and preventing infections, thereby supporting vital healthcare operations. The scope involves the timely delivery of this specific topical medication within a brief performance period. This delivery order is part of a larger ongoing pharmaceutical supply framework, ensuring agencies maintain access to essential treatments. The award followed the strategic multi-year contract framework established earlier, indicating continuity rather than a sole-source or new competitive bid. Key dates include the award and performance timeframe early in 2026. This award highlights a focused effort to replenish critical pharmaceutical stock efficiently within the established supply chain.

Description

8511951947!MAFENIDE ACETATE CR

View original record